A rapid test for simultaneous, qualitative detection of multiple drugs and drug metabolites in human urine. The assay is intended to verify an intoxication in patients. It provides a qualitative, preliminary test result.

Screens for most commonly encountered drugs of abuse groups:

• Cocaine (COC) 300 ng/mL
• Marijuana (THC) 50 ng/mL
• Methamphetamine (MET) 1,000 ng/mL
• Methylenedioxyme 500 ng/mL
• Fentanyl (FYL) 20 ng/mL
• Mephedrone (MEP) 100 mg

The Multi-Drug Rapid Test is a rapid screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in specimen.

Testing Principles

During testing, a urine specimen migrates upward by capillary action. A drug, if present in the urine specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will show up in the test region of the specific drug dipstick. The presence of drug above the cut-off concentration will saturate all the binding sites of the antibody.

Therefore, the colored line will not form in the test region. A drug-positive urine specimen will not generate a colored line in the specific test region of the dipstick because of drug competition, while a drug-negative urine specimen will generate a line in the test region because of the absence of drug competition.

To serve as a procedural control, a colored line will always appear at the control region, indicating that proper volume of specimen has been added and membrane wicking has occurred.

Expiration Date: 12/2025